Integrated Genomics Services GENEWIZ provides an end-to-end platform spanning DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory and clinical services, enabling customers to accelerate discovery and translational programs while supporting broader goals like better healthcare, environmental sustainability, and abundant food supplies.

Global Footprint With a global footprint across key biotech hubs in the United States, Europe, and Asia, GENEWIZ offers localized project management, regional regulatory support, and faster turnaround for academic, pharmaceutical, biotechnology, agricultural, government, and clinical customers.

Biomarker Expansion Recent expansions into protein biomarker detection and scRNA-Seq data analysis partnerships highlight a cross-omics capability that can accelerate drug target discovery, biomarker validation, and translational insights for industry clients.

Industry Engagement Active engagement in major industry conferences and symposia positions GENEWIZ as a thought leader and a proactive source of prospective collaborations with pharma, academic, and government buyers.

Regulatory and Clinical Strong regulatory and clinical service offerings paired with the ability to scale through strategic growth and collaborations, including the Beckman Coulter acquisition, position GENEWIZ as a preferred partner for large-scale clinical testing and long-term research programs.